Dolby Laboratories (NYSE:DLB) Stock Rating Upgraded by Wall Street Zen

Dolby Laboratories (NYSE:DLB) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.

DLB has been the subject of several other research reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday. Baird R W upgraded Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Rosenblatt Securities cut their target price on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, November 19th. Robert W. Baird started coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They set a “neutral” rating and a $74.00 price target on the stock. Finally, Barrington Research lowered their price target on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a report on Wednesday, November 19th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Dolby Laboratories currently has an average rating of “Moderate Buy” and an average price target of $92.00.

Dolby Laboratories Stock Down 0.8%

NYSE DLB opened at $66.26 on Friday. The stock has a market capitalization of $6.33 billion, a PE ratio of 25.19 and a beta of 0.89. The company has a 50 day moving average price of $66.78 and a two-hundred day moving average price of $71.16. Dolby Laboratories has a 12-month low of $64.02 and a 12-month high of $89.66.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The company had revenue of $307.02 million during the quarter, compared to the consensus estimate of $305.76 million. During the same quarter in the prior year, the company posted $0.61 EPS. The firm’s revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, equities analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current year.

Insider Buying and Selling

In other news, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $65.55, for a total value of $196,650.00. Following the sale, the senior vice president owned 67,435 shares of the company’s stock, valued at approximately $4,420,364.25. This represents a 4.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Mark Andrew Sherman sold 9,109 shares of the stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $66.73, for a total transaction of $607,843.57. Following the sale, the executive vice president owned 73,054 shares of the company’s stock, valued at $4,874,893.42. This trade represents a 11.09% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 162,120 shares of company stock valued at $10,906,559. 38.39% of the stock is owned by insiders.

Institutional Trading of Dolby Laboratories

Several large investors have recently added to or reduced their stakes in DLB. First Horizon Corp bought a new position in shares of Dolby Laboratories in the third quarter valued at approximately $25,000. Hantz Financial Services Inc. lifted its position in shares of Dolby Laboratories by 166.7% during the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after purchasing an additional 220 shares in the last quarter. MAI Capital Management lifted its position in shares of Dolby Laboratories by 87.1% during the first quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after purchasing an additional 162 shares in the last quarter. Allworth Financial LP grew its stake in shares of Dolby Laboratories by 590.4% during the second quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock valued at $37,000 after purchasing an additional 431 shares during the last quarter. Finally, Mather Group LLC. acquired a new stake in shares of Dolby Laboratories in the third quarter valued at approximately $38,000. 58.56% of the stock is owned by institutional investors.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.